By Product
Currency:CNY
2025/H1
2025/H1
2024/FY
2024/H1
2023/FY
2023/H1
2022/FY
2022/H1
2021/FY
2021/H1
2020/FY
2020/H1
2019/FY
2019/H1
2018/FY
2018/H1
2017/FY
2017/H1
2016/FY
2016/H1
2015/FY
2015/H1
2014/FY
2014/H1
2013/FY
2013/H1
2012/FY
2012/H1
2011/FY
2011/H1
2010/FY
2010/H1
2009/FY
2008/FY
2007/FY
Stock NameRevenueRatio
医药研发服务及生产外包服务收入528.77M99.06%
益生元产品收入2.78M0.52%
Rental income1.85M0.35%
Other income397.27K0.07%
By Industry
Currency:CNY
2025/H1
2025/H1
2024/FY
2024/H1
2023/FY
2023/H1
2022/FY
2021/FY
2021/H1
2020/FY
2019/FY
2019/H1
2018/FY
2017/FY
2016/FY
2015/FY
2014/FY
2014/H1
2013/FY
2013/H1
2012/FY
2011/FY
2011/H1
2010/FY
Stock NameRevenueRatio
医药研发服务及生产外包服务529.1M99.12%
微生态营养及医疗业务分部2.78M0.52%
总部及产业基金1.91M0.36%
Total special adjustments--
By Country/Region
Currency:CNY
2024/FY
2024/FY
2023/FY
2022/FY
2021/FY
2020/FY
2019/FY
2018/FY
2017/FY
2016/FY
2015/FY
2014/FY
2014/H1
2013/FY
2013/H1
2012/FY
2012/H1
2011/FY
2011/H1
2010/FY
2010/H1
2009/FY
2008/FY
2007/FY
Stock NameRevenueRatio
Overseas805.64M83.04%
Territory164.57M16.96%
